Shockwave Medical, Inc. (NASDAQ:SWAV) Shares Purchased by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. grew its stake in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) by 20.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,233 shares of the company’s stock after acquiring an additional 208 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Shockwave Medical were worth $235,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the stock. EverSource Wealth Advisors LLC increased its holdings in Shockwave Medical by 297.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company’s stock worth $31,000 after buying an additional 116 shares during the period. Asset Management One Co. Ltd. acquired a new position in Shockwave Medical in the 4th quarter worth approximately $34,000. Operose Advisors LLC acquired a new position in Shockwave Medical in the 3rd quarter worth approximately $49,000. Covestor Ltd increased its holdings in Shockwave Medical by 484.9% in the 3rd quarter. Covestor Ltd now owns 427 shares of the company’s stock worth $85,000 after buying an additional 354 shares during the period. Finally, Signaturefd LLC increased its holdings in Shockwave Medical by 79.1% in the 3rd quarter. Signaturefd LLC now owns 471 shares of the company’s stock worth $94,000 after buying an additional 208 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling at Shockwave Medical

In other Shockwave Medical news, Director Frank T. Watkins sold 2,000 shares of the firm’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $253.65, for a total value of $507,300.00. Following the transaction, the director now owns 4,532 shares in the company, valued at approximately $1,149,541.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Isaac Zacharias sold 4,000 shares of Shockwave Medical stock in a transaction on Monday, February 26th. The stock was sold at an average price of $260.36, for a total transaction of $1,041,440.00. Following the transaction, the insider now owns 61,372 shares in the company, valued at approximately $15,978,813.92. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Frank T. Watkins sold 2,000 shares of Shockwave Medical stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $253.65, for a total value of $507,300.00. Following the transaction, the director now owns 4,532 shares in the company, valued at approximately $1,149,541.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 11,521 shares of company stock worth $3,154,736. Corporate insiders own 3.40% of the company’s stock.

Shockwave Medical Trading Up 0.0 %

Shares of NASDAQ:SWAV opened at $334.15 on Friday. Shockwave Medical, Inc. has a 1 year low of $157.00 and a 1 year high of $334.28. The firm has a market capitalization of $12.54 billion, a price-to-earnings ratio of 78.07, a price-to-earnings-growth ratio of 2.43 and a beta of 0.88. The company has a debt-to-equity ratio of 0.97, a current ratio of 13.81 and a quick ratio of 12.61. The business’s 50 day moving average price is $322.64 and its 200-day moving average price is $250.57.

Shockwave Medical (NASDAQ:SWAV) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.99 by $0.45. The company had revenue of $218.80 million for the quarter, compared to analyst estimates of $207.69 million. Shockwave Medical had a return on equity of 24.79% and a net margin of 20.75%. The firm’s revenue for the quarter was up 35.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.03 EPS. On average, equities research analysts forecast that Shockwave Medical, Inc. will post 5.05 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently weighed in on SWAV shares. Wells Fargo & Company increased their price target on shares of Shockwave Medical from $200.00 to $210.00 and gave the stock an “equal weight” rating in a report on Friday, February 16th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $335.00 price objective (up previously from $270.00) on shares of Shockwave Medical in a research note on Monday, April 8th. CL King reaffirmed a “neutral” rating on shares of Shockwave Medical in a research note on Monday, April 8th. Piper Sandler raised their price objective on shares of Shockwave Medical from $290.00 to $360.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 2nd. Finally, Leerink Partnrs lowered Shockwave Medical from an “outperform” rating to a “market perform” rating in a research report on Friday, April 5th. Ten analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Shockwave Medical has a consensus rating of “Hold” and a consensus target price of $309.11.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.